361 related articles for article (PubMed ID: 32689578)
1. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Low-Dose Tirofiban for Acute Intracranial Atherosclerotic Stenosis Related Occlusion with Residual Stenosis after Endovascular Treatment.
Yan Z; Shi Z; Wang Y; Zhang C; Cao J; Ding C; Qu M; Xia Y; Cai J; Zhang X; Wang H
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104619. PubMed ID: 31982305
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients.
Zhang H; Lin F; Zhao Y; Chang W; Liu H; Yin J; Li L
J Cardiovasc Pharmacol; 2021 Sep; 78(3):448-452. PubMed ID: 34117180
[TBL] [Abstract][Full Text] [Related]
6. Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
Lin L; Li W; Liu CC; Wu Y; Huang SH; Li XS; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Feng W; Zhang M
J Neurol Sci; 2017 Dec; 383():175-179. PubMed ID: 29246609
[TBL] [Abstract][Full Text] [Related]
7. Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
; Qiu Z; Li F; Sang H; Luo W; Liu S; Liu W; Guo Z; Li H; Sun D; Huang W; Zhang M; Zhang M; Dai W; Zhou P; Deng W; Zhou Z; Huang X; Lei B; Li J; Yuan Z; Song B; Miao J; Liu S; Jin Z; Zeng G; Zeng H; Yuan J; Wen C; Yu Y; Yuan G; Wu J; Long C; Luo J; Tian Z; Zheng C; Hu Z; Wang S; Wang T; Qi L; Li R; Wan Y; Ke Y; Wu Y; Zhu X; Kong W; Huang J; Peng D; Chang M; Ge H; Shi Z; Yan Z; Du J; Jin Y; Ju D; Huang C; Hong Y; Liu T; Zhao W; Wang J; Zheng B; Wang L; Liu S; Luo X; Luo S; Xu X; Hu J; Pu J; Chen S; Sun Y; Jiang S; Wei L; Fu X; Bai Y; Yang S; Hu W; Zhang G; Pan C; Zhang S; Wang Y; Cao W; Yang S; Zhang J; Guo F; Wen H; Zhang J; Song J; Yue C; Li L; Wu D; Tian Y; Yang J; Lu M; Saver JL; Nogueira RG; Zi W; Yang Q
JAMA; 2022 Aug; 328(6):543-553. PubMed ID: 35943471
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.
Wu C; Sun C; Wang L; Lian Y; Xie N; Huang S; Zhao W; Ren M; Wu D; Ding J; Song H; Wang Y; Ma Q; Ji X
Stroke; 2019 Dec; 50(12):3481-3487. PubMed ID: 31570084
[TBL] [Abstract][Full Text] [Related]
9. Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Siebler M; Hennerici MG; Schneider D; von Reutern GM; Seitz RJ; Röther J; Witte OW; Hamann G; Junghans U; Villringer A; Fiebach JB
Stroke; 2011 Sep; 42(9):2388-92. PubMed ID: 21852609
[TBL] [Abstract][Full Text] [Related]
10. Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
Zhao W; Li S; Li C; Wu C; Wang J; Xing L; Wan Y; Qin J; Xu Y; Wang R; Wen C; Wang A; Liu L; Wang J; Song H; Feng W; Ma Q; Ji X;
JAMA Neurol; 2024 Jun; 81(6):594-602. PubMed ID: 38648030
[TBL] [Abstract][Full Text] [Related]
11. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.
Yang M; Huo X; Miao Z; Wang Y
Drugs; 2019 Apr; 79(5):515-529. PubMed ID: 30838514
[TBL] [Abstract][Full Text] [Related]
12. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
[TBL] [Abstract][Full Text] [Related]
13. Intravenous tirofiban therapy for patients with capsular warning syndrome.
Li W; Wu Y; Li XS; Liu CC; Huang SH; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Zhang M
Stroke Vasc Neurol; 2019 Mar; 4(1):22-27. PubMed ID: 31105975
[TBL] [Abstract][Full Text] [Related]
14. Tirofiban for acute ischemic stroke: systematic review and meta-analysis.
Gong J; Shang J; Yu H; Wan Q; Su D; Sun Z; Liu G
Eur J Clin Pharmacol; 2020 Apr; 76(4):475-481. PubMed ID: 31900544
[TBL] [Abstract][Full Text] [Related]
15. Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission.
Scavasine VC; Barbosa RM; Lopes Neto FDN; Germininani FMB; Bazan R; Zétola VF; Massaro AR; Lange MC
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105677. PubMed ID: 33677312
[TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation.
Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440
[TBL] [Abstract][Full Text] [Related]
17. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
[TBL] [Abstract][Full Text] [Related]
18. Safety of Intra-Arterial Tirofiban Administration in Ischemic Stroke Patients after Unsuccessful Mechanical Thrombectomy.
Zhang S; Hao Y; Tian X; Zi W; Wang H; Yang D; Zhang M; Zhang X; Bai Y; Li Z; Sun B; Li S; Fan X; Liu X; Xu G
J Vasc Interv Radiol; 2019 Feb; 30(2):141-147.e1. PubMed ID: 30611627
[TBL] [Abstract][Full Text] [Related]
19. Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
Zi W; Song J; Kong W; Huang J; Guo C; He W; Yu Y; Zhang B; Geng W; Tan X; Tian Y; Liu Z; Cao M; Cheng D; Li B; Huang W; Liu J; Wang P; Yu Z; Liang H; Yang S; Tang M; Liu W; Huang X; Liu S; Tang Y; Wu Y; Yao L; Shi Z; He P; Zhao H; Chen Z; Luo J; Wan Y; Shi Q; Wang M; Yang D; Chen X; Huang F; Mu J; Li H; Li Z; Zheng J; Xie S; Cai T; Peng Y; Xie W; Qiu Z; Liu C; Yue C; Li L; Tian Y; Yang D; Miao J; Yang J; Hu J; Nogueira RG; Wang D; Saver JL; Li F; Yang Q;
N Engl J Med; 2023 Jun; 388(22):2025-2036. PubMed ID: 37256974
[TBL] [Abstract][Full Text] [Related]
20. Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): Study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Guo ZN; Zhang KJ; Zhang P; Qu Y; Abuduxukuer R; Nguyen TN; Chen HS; Yang Y
Eur Stroke J; 2024 Jun; 9(2):510-514. PubMed ID: 38196129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
